About Us

Montfort Medical

Original%20on%20Transparent_edited.png

Established in 2014 and headquartered in Bellevue, WA, Montfort Medical is a highly focused medical technology commercialization and distribution agency dedicated to providing the US healthcare market with the most innovative and progressive technologies possible.

 

Our current offerings range from distributing Spring Healthcare COVID-19 Antibody Test Kits to proprietary molecular PCR reagents and will continue to expand as new opportunities arise in today's dynamic healthcare market. 

Montfort Medical has also had successful experience with distribution and comercialization for novel In-Vitro Diagnostics, PTA/PTCA Catheters, Interventional Guidewires, Thrombectomy, Amniotic Tissue, Cryopreserved Vascular Allografts, Co2 Angiography Devices, CTO Assist Catheters, Cadaver Training Technologies, Closure Devices, Micro Catheters, Cardiac Implant Services and Electrophysiology Diagnostics.

 

The focus behind any product or service that we help bring to life is solely based on making sure that all stakeholders involved will greatly benefit. 

 

Patients, healthcare providers, insurance carriers and hospitals.

Executive Management

IMG_0395%25252520(1)_edited_edited_edite

Jim Duchess

Founder and CEO

After graduating from Duquesne University, Jim started his career in Pittsburgh, Pennsylvania where he developed and honed his sales skills through large B2B and B2C corporations .

 

Thereafter, Jim ventured in to medical device sales with BioMedix Vascular Solutions, which then afforded him a successful opportunity in Seattle with Dr. John B. Simpson's, Avinger, Inc.

 

Jim held a private consultant agreement with ev3/Covidien (now Medtronic), which allowed for him to discover the full potential of his capabilities and knowledge in the medical device and diagnostics field.

In 2014, Jim founded Montfort Medical with the intention of creating value and benefit to all stakeholders involved within the medical technologies sector. Such projects involved a $15 million acquisition to LeMaitre Vascular and various other commercialization efforts related to the vascular and in-vitro diagnostics specialties.

Jim is steadily focused to ensure that Montfort Medical continues to be a premier commercialization and distribution agency that enables access to the most advanced medical technologies for all to benefit from.